Drug Profile
Research programme: anti-infectives - InterMed Discovery
Alternative Names: IMD 009425; IMD 020102; IMD 021365Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator InterMed Discovery
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in Germany
- 20 Aug 2007 Preclinical trials in Bacterial infections in Germany (unspecified route)